← Back to Search

Procedure

Single Arm for Healthy Subjects

N/A

Recruiting

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-36 months

Awards & highlights

Study Summary

This trial aims to study how well patients tolerate Transcranial Magnetic Stimulation (TMS) when applied to different parts of the scalp using different stimulation settings. Additionally, the trial will investigate the knee

Who is the study for?

This trial is for healthy individuals who are interested in participating in a study to assess the comfort level of TMS (Transcranial Magnetic Stimulation) when applied to different areas of the scalp and with varying stimulation settings.Check my eligibility

What is being tested?

The study aims to determine how tolerable TMS is at various scalp locations using different parameters like single pulse, rapid bursts, and repetitive stimulations. It also looks into using the knee as an alternative site for testing new TMS protocols.See study design

What are the potential side effects?

TMS may cause discomfort or pain at the stimulation site, headache, lightheadedness, or tingling sensations during or after treatment. Rarely it can induce seizures or temporary hearing changes if ear protection isn't used.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Tolerability of TMS - Scalp Location

Tolerability of TMS - Stimulation parameters (single pulse, 10 Hz, theta burst).

Secondary outcome measures

Tolerability of TMS (Knee Location)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

This will be a single arm study with measurements of scalp location and TMS stimulation parameters.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor

201 Previous Clinical Trials

31,714 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for potential participants in this research study?

"Indeed, information on clinicaltrials.gov indicates that this investigation is presently enlisting volunteers. The trial was first registered on February 12th, 2024 and had its latest update on April 3rd, 2024. This study aims to enroll a total of 40 participants from one designated site."

Answered by AI

What is the total number of participants enrolled in this clinical trial?

"Indeed, the details on clinicaltrials.gov indicate that this trial is actively seeking participants. The trial was originally posted on February 12th, 2024 and last revised on April 3rd, 2024. There are openings for enrollment of up to 40 patients at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Characterizing the Scalp Tolerability of TMS

Kevin A. Johnson, PhD RN 2024. "Characterizing the Scalp Tolerability of TMS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06354686.